Akari Therapeutics (AKTX) had the best month between 2013 and 2014 by a US stock in January 2014, returning 5,013,984.5%.

ASSET	MONTH	% RETURN
Akari Therapeutics (AKTX)	January 2014	5,013,984.51%
Processa Pharmaceuticals (PCSA)	March 2014	2,401,860.78%
Aurora Cannabis (ACB)	July 2014	694,210.67%
Castellum (CTM)	November 2013	650,300%
INVO Fertility (IVF)	May 2013	322,460.06%
TCTM Kids IT Education (VSA)	April 2014	257,531.14%
OLB (OLB)	September 2014	3,860%
Rezolute (RZLT)	January 2013	2,207.68%
Nutex Health (NUTX)	October 2014	1,566.67%
Delcath Systems (DCTH)	April 2014	1,073.77%
Almonty Industries Inc Common Shares (ALM)	June 2013	908.03%
Nutex Health (NUTX)	April 2013	900%
Andretti Acquisition Corp II Class A Ordinary Shares (POLE)	November 2014	896.73%
ImmunoPrecise Antibodies (HYFT)	September 2014	716.67%
AmpliTech (AMPG)	June 2013	680%
GeoVax Labs (GOVX)	December 2014	675%
Xenetic Biosciences (XBIO)	January 2014	650%
Lexaria Bioscience (LEXX)	March 2014	623.09%
GEE (JOB)	December 2014	572.22%
Quantum Computing (QUBT)	February 2013	566.67%
Supercom (SPCB)	March 2013	566.67%
Cosmos Health (COSM)	March 2013	550%
Ainos (AIMD)	October 2014	500%
Synergy CHC Corp Common Stock (SNYR)	April 2014	499.99%
SRx Health Solutions (SRXH)	May 2014	450%